NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

中國的Pantoprazole市場的相關調查報告書(2021年∼2025年)

Investigation Report on China's Pantoprazole Market 2021-2025

出版商 China Research and Intelligence 商品編碼 1009415
出版日期 內容資訊 英文 50 Pages
商品交期: 最快1-2個工作天內
價格
中國的Pantoprazole市場的相關調查報告書(2021年∼2025年) Investigation Report on China's Pantoprazole Market 2021-2025
出版日期: 2021年06月04日內容資訊: 英文 50 Pages
簡介

中國市場中Pantoprazole的銷售額,從2016年到2020年持續減少,銷售額2020年為11億6,200萬人民幣。另一方面,中國市場中Pantoprazole的銷售額,從2016年到2020年整體有上升趨勢,從2016年到2020年之間以3.06%的年複合成長率成長。

由於有效緩和COVID-19流行,Pantoprazole的銷售額從2016年到2020年有復甦性的成長。成Pantoprazole,有穩定的治療效果,良好的酸抑制效果,短期性的副作用較低這個優點。因此,中國的Pantoprazole的銷售額,預計今後也維持成長趨勢。

本報告提供中國的Pantoprazole市場的相關調查,市場規模和預測,價格,成長要素和機會等市場發展的影響因素分析,競爭情形,主要製造商/產品的簡介等資訊。

目錄

第1章 Pantoprazole的相關概念

  • Pantoprazole的適應症
  • 中國的Pantoprazole的開發
  • 中國的Pantoprazole的政府核准
  • COVID-19對中國的Pantoprazole銷售的影響

第2章 中國的Pantoprazole銷售(2016-2020)

  • Pantoprazole的銷售量
    • 總銷售額
    • 各地區的銷售量
  • Pantoprazole的銷售量
    • 整體銷售量
    • 各地區銷售量
  • 中國的各劑型Pantoprazole銷售(2016-2020)
    • 注射
    • 腸可溶性塗料錠
    • 腸可溶性膠囊

第3章 2020年的中國的主要Pantoprazolemeka分析

  • 主要Pantoprazolemeka的市場佔有率分析
    • 各銷售額:市場佔有率調查
    • 各銷售量:市場佔有率調查
  • Hangzhou Sino American Huadong Pharmaceutical Co., Ltd.
    • 企業簡介
    • Panlisu (Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. 的Pantoprazole)在中國的銷售
  • Nycomed GmbH
    • 企業簡介
    • PANTOLOC (Nycomed GmbH的Pantoprazole)在中國的銷售
  • Yangtze River Pharmaceutical Group Co Ltd.
    • 企業簡介
    • Weidi (Yangtze River Pharmaceutical Group Co Ltd.的Pantoprazole)在中國的銷售
  • Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.
    • 企業簡介
    • Nuoke (Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.的Pantoprazole)在中國的銷售
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd
    • 企業簡介
    • Zhuodi (Chengdu Tiantaishan Pharmaceutical Co., Ltd. 的Pantoprazole)在中國的銷售

第4章 中國的各種製造商Pantoprazole的價格(2020-2021)

  • Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. (Panlisu)
  • Nycomed GmbH (PANTOLOC)
  • Yangtze River Pharmaceutical Group Co Ltd. (Weidi)
  • Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. (Nuoke)
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Zhuodi)

第5章 中國的Pantoprazole市場預測(2021-2025)

  • 中國的Pantoprazole市場開發的有影響力的要素
    • COVID-19對中國的Pantoprazole市場的影響
    • 市場成長要素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
目錄
Product Code: 2106515

Pantoprazole is the third proton pump inhibitor marketed globally. Compared with omeprazole, it has higher selectivity and bioavailability. Pantoprazole is more stable than omeprazole and lansola under weak acid conditions. The product of Pantoprazole, developed by Byk Gulden of Germany, can treat duodenal ulcer; gastric ulcer; moderate and severe reflux esophagitis. It was approved for listing in China in 1999. By the end of 2020, there are several manufacturers in the Chinese Pantoprazole market.

According to CRI's market research, the sales value of pantoprazole in the Chinese market has declined continuously from 2016 to 2020, and its sales value reached CNY 1.162 billion in 2020. The sales value of pantoprazole in the Chinese market has shown an overall upward trend from 2016 to 2020, with a CAGR of 3.06% from 2016 to 2020.

CRI expects that with the effective alleviation of the COVID-19 epidemic, the sales of pantoprazole will have a restorative growth from 2016 to 2020. Pantoprazole has the advantages of stable curative effect, good acid suppression effect, and small short-term side effects. Therefore, the sales of pantoprazole in China will maintain a growth trend in the future.

Topics Covered:

  • The impact of COVID-19 on China's Pantoprazole market
  • Sales value of China's Pantoprazole 2016-2020
  • Competitive landscape of China's Pantoprazole market
  • Prices of Pantoprazole in China
  • Prices of Pantoprazole in China by regions and manufacturers
  • Analysis of factors affecting the development of China's Pantoprazole market
  • Prospect of China's Pantoprazole market from 2021 to 2025

Table of Contents

1 Relevant Concepts of Pantoprazole

  • 1.1 Indications for Pantoprazole
  • 1.2 Development of Pantoprazole in China
  • 1.3 Governmental Approval of Pantoprazole in China
  • 1.4 The Impact of COVID-19 on Pantoprazole sales in China

2 Sales of Pantoprazole in China, 2016-2020

  • 2.1 Sales Value of Pantoprazole
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Pantoprazole
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Pantoprazole by Dosage Form in China, 2016-2020
    • 2.3.1 Injection
    • 2.3.2 Enteric-coated Tablets
    • 2.3.3 Enteric-coated Capsules

3 Analysis of Major Pantoprazole Manufacturers in China in 2020

  • 3.1 Analysis of Market Share of Major Pantoprazole Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 Hangzhou Sino American Huadong Pharmaceutical Co., Ltd.
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Panlisu (Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. 's Pantoprazole) in China
  • 3.3 Nycomed GmbH
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of PANTOLOC (Nycomed GmbH's Pantoprazole) in China
  • 3.4 Yangtze River Pharmaceutical Group Co Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Weidi (Yangtze River Pharmaceutical Group Co Ltd.'s Pantoprazole) in China
  • 3.5 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of Nuoke (Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. 's Pantoprazole) in China
  • 3.6 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of Zhuodi (Chengdu Tiantaishan Pharmaceutical Co., Ltd. 's Pantoprazole) in China

4 Prices of Pantoprazole for Different Manufacturers in China, 2020-2021

  • 4.1 Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. (Panlisu)
  • 4.2 Nycomed GmbH (PANTOLOC)
  • 4.3 Yangtze River Pharmaceutical Group Co Ltd. (Weidi)
  • 4.4 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. (Nuoke)
  • 4.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. (Zhuodi)

5 Prospect of Chinese Pantoprazole Market, 2021-2025

  • 5.1 Influential Factors of Chinese Pantoprazole Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Pantoprazole Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Pantoprazole Injection Registration in China
  • Chart Patent Information About Pantoprazole Enteric-coated Tablets Registration in China
  • Chart Patent Information About Pantoprazole Enteric-coated Capsules Registration in China
  • Chart Sales Value of Pantoprazole Injection over the World
  • Chart Sales Value of Pantoprazole Enteric-coated Tablets over the World
  • Chart Sales Value of Pantoprazole Enteric-coated Capsules over the World
  • Chart Sales Value of Pantoprazole Injection in China, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Tablets in China, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Capsules in China, 2016-2020
  • Chart Sales Value of Pantoprazole Injection in China by Regions, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Tablets in China by Regions, 2016-2020
  • Chart Sales Value of Pantoprazole Enteric-coated Capsules in China by Regions, 2016-2020
  • Chart Sales Volume of Pantoprazole Injection in China, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Tablets in China, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Capsules in China, 2016-2020
  • Chart Sales Volume of Pantoprazole Injection in China by Regions, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Tablets in China by Regions, 2016-2020
  • Chart Sales Volume of Pantoprazole Enteric-coated Capsules in China by Regions, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Injection Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Tablets Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Enteric-coated Tablets Manufacturers in China, 2016-2020
  • Chart Market Share by Sales Value of Top Pantoprazole Enteric-coated Capsules Manufacturers in China, 2016-2020
  • Chart Sales Value and Volume of Panlisu in China, 2016-2020
  • Chart Sales Value and Volume of PANTOLOC in China, 2016-2020
  • Chart Sales Value and Volume of Weidi, 2016-2020
  • Chart Sales Value and Volume of Nuoke in China, 2016-2020
  • Chart Sales Value and Volume of Zhuodi in China, 2016-2020
  • Chart Referential Prices of Panlisu in China by Region, 2020-2021
  • Chart Referential Prices of PANTOLOC in China by Region, 2020-2021
  • Chart Referential Prices of Weidi, 2020-2021
  • Chart Referential Prices of Nuoke in China by Region, 2020-2021
  • Chart Referential Prices of Zhuodi in China by Region, 2020-2021
  • Chart Forecast on Sales Value of Pantoprazole Injection in China, 2021-2025
  • Chart Forecast on Sales Value of Pantoprazole Enteric-coated Tablets in China, 2021-2025
  • Chart Forecast on Sales Value of Pantoprazole Enteric-coated Capsules in China, 2021-2025
  • Chart Forecast on Sales Volume of Pantoprazole Injection in China, 2021-2025
  • Chart Forecast on Sales Volume of Pantoprazole Enteric-coated Tablets in China, 2021-2025
  • Chart Forecast on Sales Volume of Pantoprazole Enteric-coated Capsules in China, 2021-2025